Gritstone Bio Inc
(NAS:GRTS)
$
0.805
0.0584 (7.82%)
Market Cap: 87.40 Mil
Enterprise Value: 138.44 Mil
PE Ratio: 0
PB Ratio: 5.75
GF Score: 50/100 Gritstone bio Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2021 / 02:30PM GMT
Release Date Price:
$10.2
(+1.80%)
Salveen Jaswal Richter
Goldman Sachs Group, Inc., Research Division - VP
Good morning, everyone. I'm Salveen Richter, biotechnology analyst at Goldman Sachs. Thank you for joining us, and we're really pleased to have Gritstone with us with Andrew Allen, Co-Founder, President and CEO.
Questions & Answers
Salveen Jaswal Richter
Goldman Sachs Group, Inc., Research Division - VP
With that, Andrew, to start, the company recently change same from Gritstone Oncology to Gritstone Bio given expansion outside of oncology. Could you discuss this shift and what it really means for the future of the company?
Andrew R. Allen
Gritstone bio, Inc. - Co-Founder, President, CEO, Interim Principal Financial Officer & Director
Certainly. Well, good morning, Salveen. Thanks for having us here at your conference. Yes. So Gritstone is coming up to 6 years old. And when we began, we were focused on the new challenge in oncology that presented itself at the time, which was to figure out how to implement antigen based
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot